Pr Stéphane Oudard
- Specialty
- Oncologist, urology expert
- Title
- Head of service
- Hospital
- Hôpital Européen Georges Pompidou (Paris)
- Latest articles
-
- Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study. (Jul 10, 2026)
- GABA promotes resistance to immunotherapy in patients with TLS-positive tumors. (Jul 9, 2026)
- Cyclin E1 overexpression identifies a therapeutically relevant poor prognostic patient subgroup in high-grade serous ovarian cancer. (May 30, 2026)
- Cabozantinib in patients with non-locally pretreated brain metastases from renal cell carcinoma: Results of the multicenter phase II trial CABRAMET. (May 15, 2026)
- Integrated Prognostic Score in Metastatic Castration-resistant Prostate Cancer Treated with Cabazitaxel - A CABASTY Post Hoc Analysis Validated by Two International Prospective Phase 3 Trials. (Apr 21, 2026)